Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 580-593

  Henschen Edman, Agnes H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylation; Alternative splicing; Anticoagulant; Aspirin; Diabetes; Fibrin network structure; Glycation; Glycosylation; Heterogeneity; Hydroxylation; Oxidation; Oxidative stress.; Phosphorylation; Posttranslational modification; Procoagulant; Proteolytic degradation; Sulfation

Indexed keywords

ACETYLSALICYLIC ACID; AMINO ACID; ANTIBODY; ASPARAGINE; BLOOD CLOTTING FACTOR 12; FIBRINOGEN; FIBRINOGEN VARIANT; GLUTAMINE; LYSINE; METHIONINE; THROMBIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AUTOIMMUNE DISEASE; CANCER; CARBOXY TERMINAL SEQUENCE; CIGARETTE SMOKING; CONFERENCE PAPER; DEAMINATION; DIABETES MELLITUS; GENETIC POLYMORPHISM; GLYCATION; HUMAN; OXIDATION; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; PROTEIN PROCESSING; REACTION ANALYSIS; THROMBOCYTE;

EID: 0034972480     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03546.x     Document Type: Conference Paper

References (50)

1. Fibrinogen, fibrin and factor XIII
2. Human fibrinogen - Structural variants and functional sites
3. On the identification of beneficial and detrimental molecular forms of fibrinogen
4. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at positions Aα312 and Bβ448
5. E chain) domains
6. Structure of the human γ-fibrinogen gene. Alternate mRNA splicing near the 3′ end of the gene produces γA and γB forms of γ-fibrinogen
7. Human fibrinopeptides: Isolation, characterization and structure
8. Increased phosphorylation of human fibrinopeptide A under acute phase conditions
9. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin
10. Biosynthesis of dog fibrinogen. Characterization of nascent fibrinogen in the rough endoplasmic reticulum
11. Human fetal fibrinogen: Its characteristics of delayed fibrin formation, high sialic acid and AP peptide content are more marked in the pre-term than in term samples
12. On the occurrence and significance of tyrosine sulfate in fibrinogen
13. Hydroxyproline, a posttranslational modification of proline, is a constituent of human fibrinogen
14. Carbohydrate linkage site in the β-chain of human fibrin. Hoppe-Seyler's Z
15. 2-terminal part of γ-chain
16. Screening of adult and fetal human fibrinogen with matrix-assisted laser-desorption ionization time-of-flight (MALDI-TOF) mass spectrometry
17. Biology of disease. Carbohydrate abnormalities of N-linked plasma glycoproteins in liver disease
18. Identification of methionine sulfoxide in native and oxidized fibrinogen
19. Human fibrinogen heterogeneity: The COOH-terminal residues of defective Aα chains of fibrinogen II
20. Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the α-chain is of importance for fibrin polymerization
21. Biochemistry and measurement of fibrinogen
22. Carboxyl-terminal portions of the α chains of fibrinogen and fibrin
23. Role of the αC domains of fibrin in clot formation
24. Structural and functional characterization of proteolytic fragments derived from the C-terminal regions of bovine fibrinogen
25. Analysis of Aα251 fibrinogen: The αC domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X
26. Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction
27. Isolation and characterization of human plasma fibrinogen molecular-size-variants by high-performance liquid chromatography and amino acid sequence analysis
28. Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia
29. On the cleavage specificity of leukocyte elastase towards fibrinogen
30. Impaired coagulation of fibrinogen due to digestion of the C-terminal end of the Aα-chain by human neutrophil elastase
31. Carboxy-terminal amino acid sequences of two large variant forms of the human plasma fibrinogen γ chain
32. Large-scale preparation of S-carboxymethylated chains of human fibrin and fibrinogen and the occurrence of γ-chain variants
33. Glycated fibrinogen: A new index of short-term diabetic control
34. Fibrin gel structure in diabetic patients before and during treatment with acetylsalicylic acid: A pilot study
35. Non-clottable fibrinogen by photooxidation in blood plasma
36. Photo-oxidation of histidine as a probe for aminoterminal conformational changes during fibrinogen-fibrin conversion
37. Free radical-induced fibrinogen coagulation: Modulation of neofibe formation by concentration, pH and temperature
38. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation
39. Oxidized fibrin stimulates the activation of pro-urokinase and is the preferential substrate of human plasmin
40. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation
41. Cigarette smoke contains anticoagulants against fibrin polymerization and factor XIIIa in plasma
42. Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma
43. Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma
44. Circulating immune complexes with anti-fibrinogen IgG in a hypodysfibrinogenemic proband: Isolation, stoichiometry, and partial characterization
45. Better increase in fibrin gel porosity by low dose than by intermediate dose acetylsalicylic acid
46. Modified clotting properties of fibrinogen in presence of acetylsalicylic acid in a purified system
47. Human plasma fibrinogen heterogeneity: Evidence for an extended carboxyl-terminal sequence in a normal γ chain variant (γ′)
48. Human fibrinogen heterogeneities: Determination of the major Aα chain derivatives in blood
49. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers